1. Home
  2. CDNA vs SCL Comparison

CDNA vs SCL Comparison

Compare CDNA & SCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$17.06

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Stepan Company

SCL

Stepan Company

HOLD

Current Price

$46.62

Market Cap

1.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
SCL
Founded
1998
1932
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2007
1994

Fundamental Metrics

Financial Performance
Metric
CDNA
SCL
Price
$17.06
$46.62
Analyst Decision
Buy
Strong Buy
Analyst Count
7
1
Target Price
$27.33
$75.00
AVG Volume (30 Days)
539.5K
144.7K
Earning Date
05-13-2026
05-27-2026
Dividend Yield
N/A
3.37%
EPS Growth
N/A
N/A
EPS
N/A
2.05
Revenue
$48,324,000.00
$1,803,737,000.00
Revenue This Year
$15.37
$6.98
Revenue Next Year
$11.23
$4.69
P/E Ratio
N/A
$22.91
Revenue Growth
18.93
N/A
52 Week Low
$10.96
$41.82
52 Week High
$21.49
$68.00

Technical Indicators

Market Signals
Indicator
CDNA
SCL
Relative Strength Index (RSI) 37.34 27.75
Support Level $16.74 $41.98
Resistance Level $17.09 $50.37
Average True Range (ATR) 0.83 1.79
MACD -0.21 -0.83
Stochastic Oscillator 23.77 7.75

Price Performance

Historical Comparison
CDNA
SCL

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About SCL Stepan Company

Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.

Share on Social Networks: